Equities
  • Price (EUR)138.40
  • Today's Change0.55 / 0.40%
  • Shares traded--
  • 1 Year change+59.78%
  • Beta0.6919
Data delayed at least 15 minutes, as of Jul 14 2025 20:48 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

  • Revenue in USD (TTM)222.13bn
  • Net income in USD1.56bn
  • Incorporated1979
  • Employees48.90k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CAH:NYQ since
announced
Transaction
value
Texas Digestive Disease Consultants PLLCDeal completed11 Nov 202411 Nov 2024Deal completed33.85%2.80bn
North Coast Medical Supply LLCDeal completed11 Nov 202411 Nov 2024Deal completed33.85%1.10bn
Integrated Oncology Network LLCDeal completed20 Sep 202420 Sep 2024Deal completed45.69%1.12bn
Data delayed at least 15 minutes, as of Jul 14 2025 20:50 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.